Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mild cognitive impairment (MCI), the earliest clinically detectable phase of the trajectory toward dementia and Alzheimer's disease (AD), led to the need for even earlier detection and prevention of AD. Although it is a clinical diagnosis, its underlying neuropathological findings are just being defined. MCI is best studied in longitudinally followed patients in centers that are experienced in dementing disorders. In this review of the few major clinical-pathological reports of longitudinally followed patients, it appears that most autopsied amnestic MCI (aMCI) patients are on a pathway toward AD. Neurofibrillary pathology in entorhinal cortex, hippocampus, and amygdala--not amyloid plaques--is the major substrate for aMCI and for memory decline. In addition, many MCI patients have other concomitant pathological alterations, the most common of which are strokes, but also include argyrophilic grains and Lewy bodies. These findings are not surprising because most MCI autopsied cases have been in the older (80 to 90 year) range where these findings are common. In early AD, the phase following MCI, the significant change is an increase in neurofibrillary tangles in the neocortex that correlates with an increase in Braak score and the observed clinical progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AD pathology occurs well before (up to two decades) the onset of clinical symptoms2–4.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“It has been estimated that approximately 15 percent of people with aMCI progress to AD annually3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
In the citing paper
“Indeed, the first pathological insults to neurons in AD and aMCI occur at pre- and post-synaptic membranes1,3.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [3]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The National Institute on Aging and Reagan Institute (NIA-RI) criteria, developed in 1997 [9], use the CERAD plaque score and the Braak and Braak score to reach a likelihood of the diagnosis of AD.”
ResultInfluentialMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 1×
“[2] in two seminal publications to describe that the”
BackgroundMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851 · cited 2×
“In another report from Washington University’s Alzheimer’s Disease Research Center [17], they found that in six subjects with CDR scores of 0.5 with uncertain dementia at entry into this study, all had neuropathological AD at autopsy.”
BackgroundInfluentialHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Cited by
Items 201–235 of 235
Chen, R., & Kang, G. (2022) · International Conference on Bioinformatics and Biomedical Science (ICBBS) · doi:10.1145/3571532.3571543 · Cited by 1
“3571543 hereditary illness state that occurs in both normal persons (NC) and those with AD and is commonly referred to as the preclinical stage of the disease [2].”
BackgroundEllison, D., Love, S., Chimelli, L. M. C., Harding, B. N., Lowe, J. S., Vinters, H. V., Brandner, S., & Yong, W. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3515-0.00031-3 · Cited by 1
Wu, J., Initiative, A. D. N., Su, Y., Chen, Y., Zhu, W., Reiman, E. M., Caselli, R. J., Chen, K., Thompson, P. M., Wang, J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230034 · Cited by 2
“Since biomarkers representing the initial deterioration stage would be more interesting, we focused our study on Braak34 and explore whether the correlated MRI features carry more significant statistical power for MCI conversion prediction in the following sections.”
Morrow, J. D. (2023) · F1000Research · doi:10.12688/f1000research.140403.1 · Cited by 1
Vitamin E (Tocopherol): Implications in Cardiovascular Health and Neuroprotection
Parameswari, R., Anand, M. A. V., Wang, C., Babaujanarthanam, R., & Nagarajan, P. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_12 · Cited by 2
Sleep and Circadian Rhythms in Dementia
Harper, D. G. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch16 · Cited by 2
Abortion: taking on the hard questions.
Kissling, F. (1999) · PubMed · Cited by 1
Li, Y., Kang, J., Wu, C., Dinov, I. D., Hu, J., Chalise, P., Mahnken, J. D., & Initiative, A. D. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.29.454368 · Cited by 1
Biomarkers for Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Imaging
Bozzali, M., & Serra, L. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_10
Neuropatologia de l'Alzheimer i les esquizofrènies
Ferrer, I., & Tobeña, A. (2012) · Treballs de la Societat Catalana de Biologia
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Young, B. N. (2014) · UC Research Repository (University of Canterbury) · doi:10.26021/7842
Sensibilidad de biomarcadores en el líquido cefalorraquídeo en enfermedades neurodegenerativas
Ribas, G. G., Gómez, I. R., López-Sendón, J. L., Fernandez, M., Bascuñana, M., & de Yébenes, J. G. (2011) · Alzheimer Realidades e investigación en demencia · doi:10.5538/1137-1242.2011.49.26 · Cited by 1
Ocular biomarkers for early detection and monitoring of Alzheimer's disease
Frost, S. M. (2013) · UWA Profiles and Research Repository (UWA)
Impaired Behavioral and Pathological Outcomes Following Blast Neurotrauma
Sajja, V. S. S. S. (2013) · VTechWorks (Virginia Tech)
Walters, E. R. (2013) · Bradford Scholars (University of Bradford)
A identificação da síndrome da fragilidade no comprometimento cognitivo leve em idosos
Cezar, N. O. D. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-16052017-171439
Bourgin, J. (2019) · theses.fr (ABES) · doi:10.70675/8add514bz5e2az43e5z8976z68fcb74988ff
Microwave sensing for neurodegenerative diseases
Saied, I. (2021) · ERA · doi:10.7488/era/1022
Current awareness in geriatric psychiatry
(2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2399
Machine learning of cerebello-cerebral functional networks for mild cognitive impairment detectionPreprint
Yao, Q., Qu, L., Song, B., Wang, X., Wang, T., Ma, W., Tian, M., Shen, B., Qi, X., Zhu, D., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2663342/v1
Marco, M. D., Chauhan, S., Bocchetta, M., & Venneri, A. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111439
“The mild cognitive impairment (MCI) phase (i.e., the phase when objective deficits emerge), in fact, typically corresponds to Braak Stages II to IV (Markesbery, 2010).”
Trojanowski, J. Q., Arnold, S. E., Karlawish, J. H., Xie, S. X., & Deerlin, V. M. V. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2456-1_1
Mechanistic insights into Aβ-dependent neuronal hyperactivity in an Alzheimer’s model
Knauer, M. M., Konnerth, A., & München, T. U. (2023)
Ge, Y., Fei, Y., Ding, C., Yang, S., Fang, Y., Zheng, Y., Yin, J., Pan, Q., Zhang, N., Zhang, X., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1719981 · Cited by 1
“Mild Cognitive Impairment (MCI) is a transitional stage that falls between normal age-related cognitive decline and dementia (particularly AD), representing the earliest clinically detectable stage of progression toward dementia or AD (Markesbery, 2010).”
Deep learning for the detection of neurological diseases
Nguyen, H. (2023) · theses.fr (ABES) · doi:10.70675/25593183zc229z4451za715z96aa9ae8e073 · Cited by 4
Taylor, J. L., Hernandez, B., Lazzeroni, L. C., McNerney, M. W., Heath, A. M., Ashford, J. W., Cheng, J. J., Chao, S. Z., Priyanka, B., Iv, M., et al. (2026) · Brain Disorders · doi:10.1016/j.dscb.2026.100322
Marco, M. D., Ronch, C. D., Venneri, A., & Gallucci, M. (2026) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2026.109552
D’Amelio, C., Autelitano, S., Natale, F., Rinaudo, M., Fusco, S., & Grassi, C. (2026) · Brain Communications · doi:10.1093/braincomms/fcag345
Jaikaew, P., Pholtaisong, J., Chirdchuvutikun, P., & Lisantia, C. (2026) · Suan Sunandha Science and Technology Journal · doi:10.53848/ssstj.v13i1.1122
Metadata
- Authors
- Markesbery, W. R.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Markesbery, William R.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 221-228
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC2872776
- OpenAlex
- W1554171816
- Cited by
- 236
- References
- 35
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 8 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 17 · 2012: 22
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P30AG028383, P01AG005119, AG0 5119)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Cognition Disorders, Humans, Neurofibrillary Tangles, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.